Paul Young has over 20 years of experience in the pharmaceutical industry, leading and innovating as a pipeline builder. Young has worked in both large, multinational pharmaceutical companies and small biotech startups, where he has effectively translated disruptive technologies into successful business enterprises. With a unique career blend of science, strategy, and business development, he has delivered numerous internal R&D programs for clinical development and has secured transformational licensing deals with external parties.

Young has a passion for creating successful and productive organizations that bring innovative, breakthrough treatments to patients. Through his work in external innovation, business development, strategy, drug discovery and development, collaborations, alliances, licensing, project management, precision medicine, R&D operations, Next-Gen Pharma, Search & Evaluation, target identification, oncology, immuno-oncology, immunology, neurology, genomics, biomarkers, translational medicine, small molecules & biotherapeutics, due diligence, biotech startups, conference speaking, motivating, and networking, he has proven his ability to blend scientific vision with business sense.

Young holds a Doctor of Philosophy (Ph.D.) and a Master of Arts (M.A.) degree from Harvard University and a Bachelor of Science (B.S.) degree from Yale University. He has held various leadership positions, including Executive Director, Business Development & Licensing, Oncology at Merck, Executive Director, Head of Technologies, External Science & Innovation at Pfizer, Interim Global Head, External Innovation at EMD Serono, Inc., US Head, External Innovation at EMD Serono, Inc., Chief Scientific Officer at Syndexa Pharmaceuticals, Senior Director of Research Operations, Oncology at Sanofi, Science Site Head at Sanofi, Vice President of Research at Avalon Pharmaceuticals, Scientist at Human Genome Sciences, and Postdoctoral fellow at Genentech.